{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:08:11Z","timestamp":1779080891354,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":113,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular magnetic resonance (CMR) has transitioned from a specialist tool to a pivotal, multiparametric modality shaping diagnosis, risk, and therapy across major cardiovascular diseases; however, guideline positioning remains inconsistent between the European Society of Cardiology (ESC) and the National Institute for Health and Care Excellence (NICE). We performed a structured synthesis of contemporary ESC and NICE guidance (2015\u201325), mapping recommendation strength, evidential certainty, and pathway sequencing across heart failure, cardiomyopathies, ischaemic, and valvular disease, anchored to a curated PubMed dataset for transparency and reproducibility. Thirteen ESC and five NICE documents met the inclusion. This was a structured guideline review with narrative policy synthesis. ESC integrates CMR early with graded, disease-specific roles for morphology, tissue characterization, stress perfusion, and flow quantification; NICE adopts a more conservative, problem-solving stance, typically after echocardiography or CT triage. Concordance is strongest in heart failure and valvular disease, whereas divergence persists in cardiomyopathies and myocarditis, and in chronic coronary syndromes, where CT-first pathways dominate in NICE. These differences alter diagnostic yield, time-to-aetiology, radiation exposure, and downstream allocation to revascularization, electrophysiology, genetic testing, and surveillance, with measurable implications for equity within capacity-constrained services. Methodological drivers include ESC\u2019s emphasis on clinical utility once analytic validity is established vs. NICE\u2019s explicit cost-effectiveness modelling and deliverability thresholds. Aligning recommendations around shared outcomes, rapid-update pathways, and commissioning levers would reduce unwarranted variation while preserving fiscal responsibility. This review defines where and why CMR\u2019s value is realized or deferred in UK practice, and proposes pragmatic, evidence-linked strategies to harmonize guidance and accelerate mechanism-based care across populations, regions, and clinical acuity levels.<\/jats:p>","DOI":"10.1093\/ehjimp\/qyag079","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:31:31Z","timestamp":1776771091000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular magnetic resonance in contemporary guidelines: divergence between ESC and NICE across major cardiovascular diseases"],"prefix":"10.1093","volume":"4","author":[{"given":"Nicholas","family":"Sawh","sequence":"first","affiliation":[{"name":", Norwich Medical School, University of East Anglia Department of Cardiovascular and Metabolic Health , Research Park, Norwich NR4 7TJ ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0006-818X","authenticated-orcid":false,"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":", Norwich Medical School, University of East Anglia Department of Cardiovascular and Metabolic Health , Research Park, Norwich NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich Research Park , Norwich NR4 7UY ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-4806","authenticated-orcid":false,"given":"Gareth","family":"Matthews","sequence":"additional","affiliation":[{"name":", Norwich Medical School, University of East Anglia Department of Cardiovascular and Metabolic Health , Research Park, Norwich NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich Research Park , Norwich NR4 7UY ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Swift","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, Immunity & Cardiovascular Disease, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]},{"name":"Sheffield Biomedical Research Centre, National Institute for Health and Care Research , Sheffield S1 4DA ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-5326","authenticated-orcid":false,"given":"Amardeep","family":"Dastidar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, North Bristol NHS Trust , Bristol BS10 5NB ,","place":["UK"]},{"name":"Bristol Heart Institute Department of Cardiology, , Bristol BS2 8ED ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P","family":"Ripley","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northumbria Healthcare NHS Foundation Trust , Newcastle NE27 0QJ ,","place":["UK"]},{"name":"School of Medicine, University of Sunderland , Sunderland SR1 3SD ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P","family":"Swoboda","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds LS2 9JT ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-169X","authenticated-orcid":false,"given":"Pankaj","family":"Garg","sequence":"additional","affiliation":[{"name":", Norwich Medical School, University of East Anglia Department of Cardiovascular and Metabolic Health , Research Park, Norwich NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich Research Park , Norwich NR4 7UY ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026051800463506500_qyag079-B1","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3399\/bjgp19X702665","article-title":"Diagnosis and management of chronic heart failure: NICE guideline update 2018","volume":"69","author":"Taylor","year":"2019","journal-title":"Br J Gen Pract"},{"key":"2026051800463506500_qyag079-B4","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001081","article-title":"Comparison of NICE and ESC proposed strategies on new onset chest pain and the contemporary clinical utility of pretest probability risk score","volume":"7","author":"Papachristidis","year":"2020","journal-title":"Open Heart"},{"key":"2026051800463506500_qyag079-B5","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000406","article-title":"Comparison between National Institute for Health and Care Excellence (NICE) and European Society of Cardiology (ESC) guidelines for the diagnosis and management of stable angina: implications for clinical practice","volume":"3","author":"Archbold","year":"2016","journal-title":"Open Heart"},{"key":"2026051800463506500_qyag079-B6","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026051800463506500_qyag079-B7","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026051800463506500_qyag079-B8","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"2026051800463506500_qyag079-B9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026051800463506500_qyag079-B10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026051800463506500_qyag079-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"2026051800463506500_qyag079-B12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"2026051800463506500_qyag079-B13","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B14","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B16","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B20","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B22","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B23","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B24","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B25"},{"key":"2026051800463506500_qyag079-B26","volume-title":"Acute Heart Failure: Diagnosing and Managing Acute Heart Failure in Adults","author":"National Institute for Health and Care Excellence.","year":"2014  ( 2021)"},{"key":"2026051800463506500_qyag079-B27"},{"key":"2026051800463506500_qyag079-B28"},{"key":"2026051800463506500_qyag079-B29"},{"key":"2026051800463506500_qyag079-B30","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1038\/s41598-023-41087-4","article-title":"Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis","volume":"13","author":"Theerasuwipakorn","year":"2023","journal-title":"Sci Rep"},{"key":"2026051800463506500_qyag079-B31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","article-title":"Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis","volume":"17","author":"Kiaos","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026051800463506500_qyag079-B32","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026051800463506500_qyag079-B33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011492","article-title":"Prognostic impact of late gadolinium enhancement by cardiovascular magnetic resonance in myocarditis: a systematic review and meta-analysis","volume":"14","author":"Georgiopoulos","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026051800463506500_qyag079-B34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3399\/bjgp18X695693","article-title":"New NICE guidelines for the management of stable angina","volume":"68","author":"Dancy","year":"2018","journal-title":"Br J Gen Pract"},{"key":"2026051800463506500_qyag079-B35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7861\/clinmedicine.17-3-209","article-title":"The 2016 update to NICE CG95 guideline for the investigation of new onset stable chest pain: more innovation, but at a cost?","volume":"17","author":"Alfakih","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"2026051800463506500_qyag079-B36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"2026051800463506500_qyag079-B37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/heartjnl-2013-303624","article-title":"Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study","volume":"99","author":"Walker","year":"2013","journal-title":"Heart"},{"key":"2026051800463506500_qyag079-B38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/heartjnl-2020-316990","article-title":"Cost-effectiveness of cardiovascular imaging for stable coronary heart disease","volume":"107","author":"Walker","year":"2021","journal-title":"Heart"},{"key":"2026051800463506500_qyag079-B39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025700","article-title":"Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK","volume":"9","author":"Stokes","year":"2019","journal-title":"BMJ Open"},{"key":"2026051800463506500_qyag079-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18590","article-title":"Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy","volume":"18","author":"Campbell","year":"2014","journal-title":"Health Technol Assess"},{"key":"2026051800463506500_qyag079-B41","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/eurheartj\/ehac207","article-title":"Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications","volume":"43","author":"Garg","year":"2022","journal-title":"Eur Heart J"},{"key":"2026051800463506500_qyag079-B42","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae038","article-title":"Sex-specific cardiac magnetic resonance pulmonary capillary wedge pressure","volume":"4","author":"Garg","year":"2024","journal-title":"Eur Heart J Open"}],"container-title":["European Heart Journal - Imaging Methods and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjimp\/advance-article-pdf\/doi\/10.1093\/ehjimp\/qyag079\/68144514\/qyag079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyag079\/68144514\/qyag079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/1\/qyag079\/68144514\/qyag079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T04:47:20Z","timestamp":1779079640000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjimp\/article\/doi\/10.1093\/ehjimp\/qyag079\/8661539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjimp\/qyag079","relation":{},"ISSN":["2755-9637"],"issn-type":[{"value":"2755-9637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1,1]]},"article-number":"qyag079"}}